233 related articles for article (PubMed ID: 38531900)
1. Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology.
Goralski TM; Meyerdirk L; Breton L; Brasseur L; Kurgat K; DeWeerd D; Turner L; Becker K; Adams M; Newhouse DJ; Henderson MX
Nat Commun; 2024 Mar; 15(1):2642. PubMed ID: 38531900
[TBL] [Abstract][Full Text] [Related]
2. Spatial transcriptomics reveals molecular dysfunction associated with Lewy pathology.
Goralski T; Meyerdirk L; Breton L; Brasseur L; Kurgat K; DeWeerd D; Turner L; Becker K; Adams M; Newhouse D; Henderson MX
bioRxiv; 2023 May; ():. PubMed ID: 37292685
[TBL] [Abstract][Full Text] [Related]
3. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions.
Stoyka LE; Arrant AE; Thrasher DR; Russell DL; Freire J; Mahoney CL; Narayanan A; Dib AG; Standaert DG; Volpicelli-Daley LA
Neurobiol Dis; 2020 Feb; 134():104708. PubMed ID: 31837424
[TBL] [Abstract][Full Text] [Related]
4. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
[TBL] [Abstract][Full Text] [Related]
5. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy.
Schaser AJ; Stackhouse TL; Weston LJ; Kerstein PC; Osterberg VR; López CS; Dickson DW; Luk KC; Meshul CK; Woltjer RL; Unni VK
Acta Neuropathol Commun; 2020 Aug; 8(1):150. PubMed ID: 32859276
[TBL] [Abstract][Full Text] [Related]
6. A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.
Hartlage-Rübsamen M; Bluhm A; Moceri S; Machner L; Köppen J; Schenk M; Hilbrich I; Holzer M; Weidenfeller M; Richter F; Coras R; Serrano GE; Beach TG; Schilling S; von Hörsten S; Xiang W; Schulze A; Roßner S
Acta Neuropathol; 2021 Sep; 142(3):399-421. PubMed ID: 34309760
[TBL] [Abstract][Full Text] [Related]
7. The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.
Schulz-Schaeffer WJ
Acta Neuropathol; 2010 Aug; 120(2):131-43. PubMed ID: 20563819
[TBL] [Abstract][Full Text] [Related]
8. Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders.
Altay MF; Liu AKL; Holton JL; Parkkinen L; Lashuel HA
Acta Neuropathol Commun; 2022 Nov; 10(1):163. PubMed ID: 36371251
[TBL] [Abstract][Full Text] [Related]
9. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
Jellinger KA
Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
[TBL] [Abstract][Full Text] [Related]
10. Differential insular cortex subregional vulnerability to α-synuclein pathology in Parkinson's disease and dementia with Lewy bodies.
Fathy YY; Jonker AJ; Oudejans E; de Jong FJJ; van Dam AW; Rozemuller AJM; van de Berg WDJ
Neuropathol Appl Neurobiol; 2019 Apr; 45(3):262-277. PubMed ID: 29797340
[TBL] [Abstract][Full Text] [Related]
11. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
12. Seeding of protein aggregation causes cognitive impairment in rat model of cortical synucleinopathy.
Espa E; Clemensson EKH; Luk KC; Heuer A; Björklund T; Cenci MA
Mov Disord; 2019 Nov; 34(11):1699-1710. PubMed ID: 31449702
[TBL] [Abstract][Full Text] [Related]
13. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.
Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073
[TBL] [Abstract][Full Text] [Related]
14. Pathology-associated change in levels and localization of SIDT2 in postmortem brains of Parkinson's disease and dementia with Lewy bodies patients.
Fujiwara Y; Kabuta C; Sano T; Murayama S; Saito Y; Kabuta T
Neurochem Int; 2022 Jan; 152():105243. PubMed ID: 34800582
[TBL] [Abstract][Full Text] [Related]
15. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
16. Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders.
Patterson L; Rushton SP; Attems J; Thomas AJ; Morris CM
Brain Pathol; 2019 Jul; 29(4):544-557. PubMed ID: 30582885
[TBL] [Abstract][Full Text] [Related]
17. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
Galiano-Landeira J; Torra A; Vila M; Bové J
Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge.
Miraglia F; Betti L; Palego L; Giannaccini G
Cent Nerv Syst Agents Med Chem; 2015; 15(2):109-16. PubMed ID: 25896035
[TBL] [Abstract][Full Text] [Related]
19. Loss of nuclear REST/NRSF in aged-dopaminergic neurons in Parkinson's disease patients.
Kawamura M; Sato S; Matsumoto G; Fukuda T; Shiba-Fukushima K; Noda S; Takanashi M; Mori N; Hattori N
Neurosci Lett; 2019 Apr; 699():59-63. PubMed ID: 30684677
[TBL] [Abstract][Full Text] [Related]
20. The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease.
Henderson MX; Henrich MT; Geibl FF; Oertel WH; Brundin P; Surmeier DJ
Neurobiol Dis; 2022 Jun; 168():105687. PubMed ID: 35283326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
